| [1] |
Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world[J]. World J Urol, 2017, 35: 1301-1320.
|
| [2] |
Sancak EB, Reorlu M, Akbas A, et al. Do Hyperten-sion, diabetes mellitus and obesity increase the risk of severity of nephrolithiasis?[J]. Pak J Med Sci, 2015, 31: 566-671.
|
| [3] |
Miller NL, Gillen DL, Williams JC Jr, et al. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque[J]. BJU Int, 2009, 103: 966-971.
|
| [4] |
Moor MB, Bonny O. Ways of calcium reabsorption in the kidney[J]. Am J Physiol Renal Physiol, 2016, 310: 1337-1350.
|
| [5] |
Breiderhoff T, Himmerkus N, Drewell H, et al. Deletion of claudin-10 rescues claudin-16-deficient mice from hypomagnesemia and hypercalciuria[J]. Kidney Int, 2018, 93: 580-588.
|
| [6] |
Khan SR, Pearle MS, Robertson WG, et al. Kidney stones[J]. Nat Rev Dis Primers, 2017, 3: 1700-1710.
|
| [7] |
Convento M, Pessoa E, Arago A, et al. Oxalate induces type Ⅱ epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo[J]. Oncotarget, 2019, 10: 1102-1118.
|
| [8] |
Joshi S, Clapp WL, Wang W, et al. Osteogenic changes in kidneys of hyperoxaluric rats[J]. Biochim Biophys Acta, 2015, 1852: 2000-2012.
|
| [9] |
Priante G, Ceol M, Gianesello L, et al. Human proximal tubular cells can form calcium phosphate deposits in osteogenic culture: role of cell death and osteoblast-like transdifferentiation[J]. Cell Death Discov, 2019, 5: 57-65.
|
| [10] |
Alelign T, Petros B. Kidney stone disease: an update on current concepts[J]. Adv Urol, 2018, 6: 306-325.
|
| [11] |
Liu Y, Li D, He Z, et al. Inhibition of autophagy-attenuated calcium oxalate crystal-induced renal tubular epithelial cell injury in vivo and in vitro[J]. Oncotarget, 2018, 9: 4571-4582.
|
| [12] |
Chaiyarit S, Thongboonkerd V. Mitochondrial dysfunction and kidney stone disease[J]. Front Physiol, 2020, 11: 566-576.
|
| [13] |
Sun XY, Zhang H, Liu J, et al. Repair activity and crystal adhesion inhibition of polysaccharides with differ-ent molecular weights from red algae Porphyra yezoensis against oxalate-induced oxidative damage in renal epithelial cells[J]. Food Funct, 2019, 10: 3851-3867.
|
| [14] |
Taguchi K, Hamamoto S, Okada A, et al. Genome-wide gene expression profiling of Randall's plaques in calcium oxalate stone formers[J]. J Am Soc Nephrol, 2017, 28: 333-347.
|
| [15] |
Okada A, Nomura S, Higashibata Y, et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection[J]. Urol Res, 2007, 35: 89-99.
|
| [16] |
Taguchi K, Okada A, Hamamoto S, et al. M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development[J]. Sci Rep, 2016, 6: 351-367.
|
| [17] |
Liu Q, Liu Y, Guan X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals[J]. Kidney Blood Press Res, 2019, 44: 777-791.
|
| [18] |
Wang J, Cao B, Han D, et al. Long non-coding RNA H19 induces cerebral ischemia reperfusion injury via activation of autophagy[J]. Aging Dis, 2017, 8: 71-84.
|
| [19] |
Liu H, Ye T, Yang X, et al. H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway[J]. EBioMedicine, 2019, 50: 366-378.
|
| [20] |
Wang Z, Zhang JW, Zhang Y, et al. Analyses of long non-coding RNA and mRNA profiling using RNA sequencing in calcium oxalate monohydrate-stimulated renal tubular epithelial cells[J]. Urolithiasis, 2019, 47: 225-234.
|
| [21] |
Song Z, Zhang Y, Gong B, et al. Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone[J]. J Cell Biochem, 2019, 120: 10452-10462.
|
| [22] |
Wahl P, Ducasa GM, Fornoni A. Systemic and renal lipids in kidney disease development and progression[J]. Am J Physiol Renal Physiol, 2016, 310: 433-445.
|
| [23] |
Cohen AJ, Adamsky MA, Nottingham CU, et al. Impact of statin intake on kidney stone formation[J]. Urology, 2019, 124: 57-61.
|
| [24] |
Dominguez-Gutierrez PR, Kwenda EP, Khan SR, et al. Immunotherapy for stone disease[J]. Curr Opin Urol, 2020, 30: 183-189.
|
| [25] |
Zhu W, Zhao Z, Chou F, et al. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals[J]. Cell Death Dis, 2019, 10: 275-284.
|
